Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Booth

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|May 20, 2020
Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM CellsPaul Dent, Laurence Booth, Jane L Roberts, et al.
Oncotarget|February 8, 2024
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cellsMichael R Booth, Laurence Booth, Jane L Roberts, et al.
Frontiers in Oncology|February 13, 2020
Fingolimod Augments Monomethylfumarate Killing of GBM CellsPaul Dent, Laurence Booth, Jane L Roberts, et al.
Cellular Signalling|January 9, 2020
Enhanced signaling via ERBB3/PI3K plays a compensatory survival role in pancreatic tumor cells exposed to [neratinib + valproate]Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Oncotarget|January 17, 2022
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cellsLaurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget|February 9, 2022
GZ17-6.02 and axitinib interact to kill renal carcinoma cellsLaurence Booth, Cameron West, Robert P Moore, et al.
Molecular Cancer Therapeutics|September 5, 2019
Editor's Note: Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress-Inducing DrugsLaurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Molecular Cancer Therapeutics|August 9, 2014
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugsLaurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Oncotarget|April 9, 2026
The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cellsMichael R Booth, Laurence Booth, Jane L Roberts, et al.
Cancer Biology & Therapy|September 20, 2012
OSU-03012 interacts with lapatinib to kill brain cancer cellsLaurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|May 20, 2020
Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM CellsPaul Dent, Laurence Booth, Jane L Roberts, et al.
Oncotarget|February 8, 2024
GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cellsMichael R Booth, Laurence Booth, Jane L Roberts, et al.
Frontiers in Oncology|February 13, 2020
Fingolimod Augments Monomethylfumarate Killing of GBM CellsPaul Dent, Laurence Booth, Jane L Roberts, et al.
Cellular Signalling|January 9, 2020
Enhanced signaling via ERBB3/PI3K plays a compensatory survival role in pancreatic tumor cells exposed to [neratinib + valproate]Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Oncotarget|January 17, 2022
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cellsLaurence Booth, Cameron West, Robert P Moore, et al.
Oncotarget|February 9, 2022
GZ17-6.02 and axitinib interact to kill renal carcinoma cellsLaurence Booth, Cameron West, Robert P Moore, et al.
Molecular Cancer Therapeutics|September 5, 2019
Editor's Note: Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress-Inducing DrugsLaurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Molecular Cancer Therapeutics|August 9, 2014
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugsLaurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Oncotarget|April 9, 2026
The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cellsMichael R Booth, Laurence Booth, Jane L Roberts, et al.
Cancer Biology & Therapy|September 20, 2012
OSU-03012 interacts with lapatinib to kill brain cancer cellsLaurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Pageof 10